Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 8/20 | 0.51 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.37 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.37 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.37 |
| ▸ | CD40 | P25942 | 1/20 | 0.36 |
| ▸ | CD40LG | P29965 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.36 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.36 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.36 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14981561 | 0.86 | ENPP2 (0.54) | ENPP2FUT8CYP1A2PHLPP2PRMT3 | |
| SCHEMBL18218144 | 0.83 | FUT8 (0.56) | ENPP2FUT8CYP1A2PHLPP2PRMT1 | |
| SCHEMBL12172927 | 0.83 | FUT8 (0.56) | ENPP2FUT8CYP1A2PHLPP2PRMT1 | |
| SCHEMBL13481857 | 0.83 | ENPP2 (0.48) | ENPP2FUT8CYP1A2PHLPP2PRMT3 | |
| SCHEMBL16387115 | 0.82 | ENPP2 (0.51) | ENPP2FUT8CYP1A2PHLPP2PRMT3 | |
| SCHEMBL12943143 | 0.80 | ENPP2 (0.68) | ENPP2CYP1A2PHLPP2PRMT3EP300 | |
| SCHEMBL18218142 | 0.79 | FUT8 (0.62) | ENPP2FUT8CYP1A2PHLPP2CD40 | |
| SCHEMBL14134065 | 0.78 | ENPP2 (0.46) | ENPP2FUT8CYP1A2PHLPP2PRMT3 | |
| SCHEMBL13481841 | 0.78 | ENPP2 (0.44) | ENPP2FUT8CYP1A2PHLPP2PRMT3 | |
| SCHEMBL16557867 | 0.78 | ENPP2 (0.45) | ENPP2FUT8CYP1A2PHLPP2PRMT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | ENPP2 1649/4885FUT8 769/4885CYP1A2 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.